Waldenström's macroglobulinemia differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Waldenström's macroglobulinemia}} | {{Waldenström's macroglobulinemia}} | ||
==References== | Waldenström's macroglobulinemia must be differentiated from other B cell lymphoid neoplasms including:<ref name="UTD">Clinical manifestations, pathologic features, and diagnosis of lymphoplasmacytic lymphoma. UpToDate (2015)http://www.uptodate.com/contents/clinical-manifestations-pathologic-features-and-diagnosis-of-lymphoplasmacytic-lymphoma?source=see_link§ionName=PATHOGENESIS&anchor=H198194648#H198194648 Accessed on November 9, 2015</ref> | ||
*Chronic lymphocytic leukemia/small lymphocytic lymphoma: | |||
::*Always express CD5, usually CD23 positive | |||
*B-cell prolymphocytic leukemia: | |||
::*Express bright surface IgM, CD20 and other B-cell antigens (CD19, CD22, CD79a, FMC7) | |||
*Follicular lymphoma: | |||
::*Express CD10, HLA-DR, pan B-cell antigens (CD19, CD20, CD79a), CD21, and surface IgM, IgG, or IgA | |||
*Multiple myeloma: | |||
::*Express CD138, CD38, CD79a, and VS38c and CD56(70%) | |||
*Mantle cell lymphoma: | |||
::* Express CD5+ and CD23-, surface IgM and IgD and cyclin D1 in majority of cases | |||
*Marginal zone lymphoma: | |||
::*Expresses B cell markers CD19, CD20, and CD22 | |||
=References== | |||
{{reflist|2}} | {{reflist|2}} | ||
| Line 9: | Line 30: | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Blood]] | [[Category:Blood]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Revision as of 20:12, 9 November 2015
|
Waldenström's macroglobulinemia Microchapters |
|
Differentiating Waldenström's macroglobulinemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Waldenström's macroglobulinemia differential diagnosis On the Web |
|
American Roentgen Ray Society Images of Waldenström's macroglobulinemia differential diagnosis |
|
FDA on Waldenström's macroglobulinemia differential diagnosis |
|
CDC on Waldenström's macroglobulinemia differential diagnosis |
|
Waldenström's macroglobulinemia differential diagnosis in the news |
|
Blogs on Waldenström's macroglobulinemia differential diagnosis |
|
Directions to Hospitals Treating Waldenström's macroglobulinemia |
|
Risk calculators and risk factors for Waldenström's macroglobulinemia differential diagnosis |
Waldenström's macroglobulinemia must be differentiated from other B cell lymphoid neoplasms including:[1]
- Chronic lymphocytic leukemia/small lymphocytic lymphoma:
- Always express CD5, usually CD23 positive
- B-cell prolymphocytic leukemia:
- Express bright surface IgM, CD20 and other B-cell antigens (CD19, CD22, CD79a, FMC7)
- Follicular lymphoma:
- Express CD10, HLA-DR, pan B-cell antigens (CD19, CD20, CD79a), CD21, and surface IgM, IgG, or IgA
- Multiple myeloma:
- Express CD138, CD38, CD79a, and VS38c and CD56(70%)
- Mantle cell lymphoma:
- Express CD5+ and CD23-, surface IgM and IgD and cyclin D1 in majority of cases
- Marginal zone lymphoma:
- Expresses B cell markers CD19, CD20, and CD22
References=
- ↑ Clinical manifestations, pathologic features, and diagnosis of lymphoplasmacytic lymphoma. UpToDate (2015)http://www.uptodate.com/contents/clinical-manifestations-pathologic-features-and-diagnosis-of-lymphoplasmacytic-lymphoma?source=see_link§ionName=PATHOGENESIS&anchor=H198194648#H198194648 Accessed on November 9, 2015